Cancer stroma has a profound influence on tumor development and progression. The conversion of fibroblasts to activated myofibroblasts is a hallmark of reactive tumor stroma. Among a number of factors involved in this conversion, transforming growth factor (TGF)-b has emerged as a major regulator. CLIC4, an integral protein in TGF-b signaling, is highly upregulated in stroma of multiple human cancers, and overexpression of CLIC4 in stromal cells enhances the growth of cancer xenografts. In this study, we show that conditioned media from tumor cell lines induces expression of both CLIC4 and the myofibroblast marker alpha smooth muscle actin (a-SMA) in stromal fibroblasts via TGF-b signaling. Genetic ablation of CLIC4 in primary fibroblasts prevents or reduces constitutive or TGF-b-induced expression of a-SMA and extracellular matrix components that are markers of myofibroblasts. CLIC4 is required for the activation of p38 map kinase by TGF-b, a pathway that signals myofibroblast conversion in stromal cells. This requirement involves the interaction of CLIC4 with PPM1a, the selective phosphatase of activated p38. Conditioned media from fibroblasts overexpressing CLIC4 increases tumor cell migration and invasion in a TGF-b-dependent manner and promotes epithelial to mesenchymal transition indicating that high stromal CLIC4 serves to enhance tumor invasiveness and progression. Thus, CLIC4 is significantly involved in the development of a nurturing tumor microenvironment by enhancing TGF-b signaling in a positive feedback loop. Targeting CLIC4 in tumor stroma should be considered as a strategy to mitigate some of the tumor enhancing effects of the cancer stroma.
INTRODUCTION
CLIC4 (chloride intracellular channel 4) is a p53 and transforming growth factor (TGF)-b regulated, 28 kD member of a family of seven CLIC proteins that are ubiquitously expressed in various tissue types and participate in diverse biological functions. 1, 2 CLICs are structural homologs of the glutathione-S-transferase superfamily of proteins and are redox regulated. CLIC4 is dimorphic, found both in soluble form in the cytosol as well as in organellar membranes. [3] [4] [5] CLIC4 has putative chloride ion selective channel activity with single channel conductance in biological and artificial membranes. 6 In soluble form, CLIC4 contributes to vasculogenesis by promoting endothelial cell proliferation and lumen formation. 7, 8 Notably, CLIC4 knockout (KO) mice have defective angiogenesis 8, 9 and poor skin wound healing. 10 Expression of CLIC4 is markedly upregulated in the adjacent stroma of multiple human cancers, colocalizing with alpha smooth muscle actin (a-SMA), a marker of cancer stroma. 11, 12 Exogenous expression of CLIC4 in stromal fibroblasts enhances the growth of human breast carcinoma cells in xenografts. 12 These properties of CLIC4 in human cancers suggest the protein participates in tumor growth through a microenvironmental function that has not been elucidated. CLIC4 is upregulated by TGF-b and is an integral component of TGF-b signaling through its action in preventing the dephosphorylation of phospho-Smad2 and 3 in the nucleus. 13, 14 Previous studies have shown that CLIC4 is the most upregulated gene during TGF-b-mediated myofibroblast conversion of primary human breast fibroblasts and contributes to their stationary phenotype. 11 Furthermore, overexpression of CLIC4 in human fibroblasts induces a-SMA expression. 12 Located vicinal to the neoplastic epithelial cells, myofibroblasts are specialized fibroblasts that secrete growth factors, cytokines and matrix metalloproteinases. They actively promote tumor growth through their interactions with carcinoma cells changing the latter phenotypically and biochemically. 15, 16 As both expression and xenograft studies in vivo provide compelling evidence that CLIC4 participates in the promotion of a human cancer stroma, we used an in vitro model system to study the functional contributions of CLIC4 in the cancer stroma and to elucidate the mechanisms involved.
RESULTS

Tumor cells induce CLIC4 and a-SMA in surrounding fibroblasts via TGF-b signaling
We used several in vitro models to investigate the underlying mechanisms that mediate the upregulation of CLIC4 in cancer stroma, the biological consequences of upregulation and its relation to a-SMA expression. To test whether the increase in stromal CLIC4 seen in multiple cancers could be a tumor cell-driven process, we treated primary dermal fibroblasts with conditioned media from mouse and human cancer cell lines. Conditioned media from human mammary cancer (MII, III, IV) 17, 18 and mouse squamous cancer PAM212 cell lines increased the expression of CLIC4 protein in fibroblasts compared with non-tumorigenic cell lines (S1 and MI) indicating that these tumor cells acted on the stroma in a paracrine way to upregulate CLIC4 (Figure 1a , left panel). CLIC4 expression is TGF-b regulated. 13 Enzyme-linked immunosorbent assay analysis of conditioned media shows that these tumor cells secrete TGF-b (Figure 1a , right panel) and the amount increases with increasing invasiveness indicating that increased TGF-b might contribute to the progressively enhanced CLIC4 expression. TGF-b treatment of fibroblasts enhances CLIC4 (Figure 1b , left panel), and this is concurrent with increase in a-SMA expression. Notably, these proteins are co-expressed in the same cells (Figure 1b, right panel) as shown by immunofluorescence. The increase in CLIC4 expression by tumor-conditioned media occurs at the transcriptional level and coincides with induction of a-SMA transcripts (gene name Acta2; Figure 1c ) consistent with the progressive increase in TGF-b levels in these conditioned media. Treatment of Figure 1 . Tumor cells induce CLIC4 and a-SMA expression in fibroblasts via TGF-b signaling. (a) Left: primary mouse dermal fibroblasts were treated with serum-free-conditioned media from either of the human breast cell lines MI, MII, MIII or MIV or the murine squamous cell lines S1 or PAM 212 cells. Expression of CLIC4 was analyzed by immunoblotting. Right: TGF-b concentrations in conditioned media from human and mouse cell lines were determined by enzyme-linked immunosorbent assay (ELISA) and normalized to total protein content. Data sets were compared for statistical significance with MI or S1 (non-tumorigenic lines). (b) Primary dermal fibroblasts were treated for different time periods with TGF-b (10 ng/ml) and immunoblotted (left) for CLIC4 and a-SMA. Right: co-immunofluorescence for CLIC4 (green) and a-SMA (red) in primary untreated fibroblasts or fibroblasts treated with TGF-b for 48 h. (c) Primary dermal fibroblasts were treated with conditioned media as in (a) with or without pre-treatment with the ALK5 inhibitor SB431542 (5 mM). Expression of CLIC4 and a-SMA (gene name Acta2) was analyzed by real-time PCR normalized to respective glyceraldehyde 3-phosphate dehydrogenase (GAPDH) levels and plotted as relative to MI or S1. Data sets were compared as indicated by lines for statistical significance.
fibroblasts with ALK5 blocker SB431542 before conditioned medium treatment abolishes both tumor-induced CLIC4 and a-SMA expression. These results indicate that expression of CLIC4 and a-SMA in stromal fibroblasts is regulated by TGF-b released by tumor cells.
CLIC4 is required for TGF-b-dependent conversion of fibroblasts to myofibroblasts
To determine if CLIC4 is required for fibroblast to myofibroblast conversion, we used the Cre-lox system to delete exon 2 of CLIC4 in floxed mice. 10 Fibroblasts isolated from these mice were ablated of CLIC4 in vitro by adenoviral expression of Cre recombinase. In response to TGF-b (Figures 2a and b ), CLIC4 null fibroblasts did not convert to myofibroblasts as defined by induced expression of a-SMA and cell spreading. The induction of a-SMA transcript by TGF-b requires the presence of CLIC4 in fibroblasts ( Figure 2c ). Furthermore, the expression of exogenous CLIC4 by adenoviral transduction enhances a-SMA expression even in the absence of TGF-b treatment and further enhances the induction by TGF-b ( Supplementary Figure 1 ). Myofibroblasts have a central role in the synthesis, degradation and remodeling of the extracellular matrix, a process that is TGF-b regulated. 19 CLIC4 ablated fibroblasts have reduced basal and TGF-b-induced expression of ECM genes Timp1, Itga5, Mmp9, Icam1, Mmp14, Thbs1 and TGF-b1 compared with their wild-type counterparts ( Figure 2d ). Myofibroblasts are also characterized by a reduced motility and rate of migration. 20,21 CLIC4 ablated fibroblasts have greater mobility compared with wild-type fibroblasts in the presence of TGF-b (Figure 2e ). This implies that TGF-b reduces fibroblast motility owing to their myofibroblast conversion, 21 but has a smaller influence on fibroblasts devoid of CLIC4. Thus, in the absence of CLIC4, TGF-b-induced fibroblast to myofibroblast conversion is greatly impaired by multiple parameters.
TGF-b regulates myofibroblast conversion via p38MAPK signaling TGF-b signals through Smad-dependent and -independent pathways to affect cellular responses. On TGF-b treatment, CLIC4 ablated fibroblasts had markedly reduced activation of p38MAPK and a small decrease in activated Smads2/3 and p-ERK1/2 ( Figure 3a ). Chemical blockade of ERK1/2 signaling using PD98059 ( Figure 3b ) did not reduce the level of TGF-b-induced a-SMA transcript, and small interfering RNA knockdown of Smad2 ( Figure 3c ) had only a partial effect. In contrast, p38MAPK blockade using SB203580 substantially inhibited the capacity of TGF-b to upregulate a-SMA expression ( Figure 3d ).To assess a possible contribution of Smad3 in a-SMA induction, we used primary fibroblasts from Smad3 KO or wild-type mice. As shown in Figure 3e , a-SMA expression was lower (although statistically not significant) in Smad3 KO fibroblasts at the basal level and on TGF-b treatment, indicating a potential partial role for Smad3 in the regulation of a-SMA in fibroblasts. However, the basal and induced levels of a-SMA were markedly reduced by SB203580 pre-treatment ( Figure 3e ) indicating a major function for the p38 pathway in TGF-b-mediated a-SMA expression. Combined loss-offunction of Smad2 and Smad3 by small interfering RNA-mediated knockdown of Smad2 in Smad3 KO fibroblasts did not reduce a-SMA expression significantly more than knockdown of Smad2 alone (Figure 3f ). In keratinocytes, TGF-b causes CLIC4 nuclear translocation in conjunction with Schnurri-2, and nuclear CLIC4 prolongs Smad signaling by inhibiting phospho-Smad2/3 interaction with the phosphatase PPM1a. 13 Similarly, Schnurri-2 is equally abundant in fibroblasts, ( Supplementary Figure 2a) , and CLIC4 inhibits the interaction of phospho-Smads with PPM1a ( Supplementary Figure 2b ). Thus, this mechanism defined in keratinocytes is also intact in TGF-b-treated fibroblasts, but the targeting of CLIC4 on TGF-b-mediated p38 activation appears to be the dominant pathway responsible for the regulation of fibroblast to myofibroblast conversion by TGF-b. We further defined the p38 isoform responsible for TGF-b-dependent a-SMA expression in primary dermal fibroblasts. On small interfering RNA-mediated knockdown of p38a, p38b and p38d independently, PCR analysis showed that a-SMA expression is most compromised when p38a expression is reduced and unaffected by ablation of p38d ( Supplementary Figure 3 ).
CLIC4 reduces p38 dephosphorylation
We next examined the interaction of CLIC4 with p38. Studies have shown that in addition to Smad2/3, 22 PPM1a dephosphorylates other phospho-proteins including p38, MKK6, JNK and SEK1, 23 CDK2 and CDK6, 24 and IKKb 25 leading to inactivation. Figure 4 indicates that dephosphorylation of p38 in fibroblasts is modified by CLIC4. In the absence of fibroblast CLIC4, more phospho-p38 was associated with PPM1a in co-immunoprecipitation assays than was associated in wild-type fibroblasts (Figure 4a ) and the content of p-p38 is reduced (Figure 4a , input p-p38). Conversely, in fibroblasts overexpressing CLIC4, as seen in cancer stroma, the amount of phospho-p38 that co-immunoprecipitates with PPM1a ( Figure 4b ) is reduced, indicating that CLIC4 interferes with the interaction of phospho-p38 with its primary phosphatase, PPM1a, resulting in higher levels of activated p38 (Figure 4b , input p-p38). CLIC4 and PPM1a co-immunoprecipitate in pull down experiments in lysates from fibroblasts overexpressing CLIC4 (Figure 4b ), raising the possibility that CLIC4 interaction with PPM1a might cause reduced binding of PPM1a to multiple substrates.
Stromal CLIC4 enhances migration, invasion and epithelial to mesenchymal transition (EMT) of tumor cells
As CLIC4 is highly expressed in cancer stroma in vivo, 12 we examined the potential consequences of high stromal CLIC4 on tumor cells in vitro. Migration of PAM212 cells was enhanced when treated with conditioned medium from adeno-CLIC4-overexpressing fibroblasts when compared with medium conditioned by control fibroblasts infected with the adeno-vector only (Figure 5a ). Notably, the effect of conditioned medium from CLIC4-overexpressing fibroblasts was lost on pre-treatment of PAM212 cells with the ALK5 blocker SB431542 (Figure 5b ). This suggests that stromal CLIC4 via TGF-b signaling imparts an enhanced migratory capacity to PAM212 cells. When conditioned media from CLIC4-overexpressing fibroblasts was placed in the lower chamber in a matrigel invasion assay (Figure 5c ), a greater number of PAM212 cells migrated across the matrigel when compared with control conditioned medium. Pre-treatment of PAM212 cells with SB431542 and presence of SB431542 in the conditioned media ablated the effect of conditioned media on invasion. When TGF-b and hepatocyte growth factor (HGF) were used as chemoattractants in the lower chamber, SB431542 blocked TGF-b-dependent invasion but not hepatocyte growth factor-dependent invasion of PAM212 cells, indicating the specificity of SB431542 for blocking TGF-b activity. Enhanced migration and invasion could be a consequence of these tumor cells undergoing EMT. 26 Figure 5d shows that conditioned media from CLIC4-overexpressing fibroblasts suppressed expression of E-cadherin and upregulated vimentin in PAM212 cells, two molecular events that characterize EMT. Enzyme-linked immunosorbent assay of conditioned media confirmed that fibroblastconditioned medium contained considerable amounts of TGF-b, which was greater in medium from fibroblasts expressing exogenously elevated levels of CLIC4 (Figure 5e ). To confirm that squamous tumor cells were sensitive to stromal CLIC4 in vivo, we constructed a xenograft model at the orthotopic site on the dorsal skin with human SCC13 keratinocytes 27 mixed with stromal fibroblasts modified to induce exogenous CLIC4 on treatment of the host with doxycycline ( Supplementary Figure 4a ). Although tumor size increased in parallel before CLIC4 induction, subsequent growth was accelerated substantially once CLIC4 was induced in the stroma. Correspondingly, 100% (5/5) of orthografts of oncogenic ras transformed wild-type primary keratinocytes formed well-differentiated squamous cell carcinomas in wild-type hosts while only 1/5 of the same donor cells were tumorigenic in CLIC4 KO hosts ( Supplementary  Figure 4b ).
DISCUSSION
The importance of the tumor stroma has long been appreciated and it is now widely accepted that tumor-associated fibroblasts and myofibroblasts are pivotal in supporting tumor growth, progression and invasion. 28, 29 In this study, we show that endogenous fibroblast CLIC4 is important for TGF-b-driven conversion of fibroblasts to myofibroblasts. The importance of CLIC4 in the cancer stroma is likely to be physiologically significant because tumor cells themselves upregulate CLIC4 expression in the vicinal stroma (this study) and fibroblasts overexpressing CLIC4 enhance tumor growth in vivo. 12 Tumor cells cause a variety of changes in their surroundings to aid their own prosperity. Our data indicate that the paracrine activity of tumor cells responsible for CLIC4 induction is through TGF-b signaling. TGF-b is a key cancer cellderived cytokine that affects the stromal compartment to enhance matrix remodeling, secrete other growth and angiogenic factors, produce anti-apoptotic molecules and stimulate cancer progression. [30] [31] [32] This is accomplished by stimulating conversion of stromal fibroblasts into myofibroblasts. 33 We show that cell lines with increasing tumorigenicity secrete progressively higher levels of TGF-b and induce CLIC4 and a-SMA expression coordinately suggesting that CLIC4 is a key mediator in the TGF-b regulated myofibroblast conversion program and hence contributes to cancer progression.
In the absence of CLIC4, myofibroblast conversion is markedly reduced, at least as measured by a-SMA expression. a-SMA-positive myofibroblasts are major components of the tumor microenvironment and modulate tumor growth in a paracrine way. 34 a-SMA expression imparts greater contractility to the fibroblasts. 35, 36 Stromal expression of a-SMA is a marker of aggressive basal cell carcinoma 34 and predicts disease recurrence in colorectal cancer. 37 Our data suggest that CLIC4 is integral to the TGF-bdependent induction of a-SMA via p38MAPK activation. A number of signaling pathways mediated by TGF-b have been implicated in myofibroblast conversion of fibroblasts. The induction of a-SMA in lung myofibroblasts is controversial and has been reported to be either Smad2, Smad3 or Erk dependent [38] [39] [40] [41] in different analyses. p38 inhibitors prevent myofibroblast conversion of human tendon fibroblasts. 42 Similarly, it is the activation of p38MAPK that we find the most compelling evidence for regulating TGF-b-mediated a-SMA expression in murine primary dermal fibroblasts. Although Smad2 had a partial effect, Smad3 knockdown or Erk blockade did not reduce a-SMA expression in these fibroblasts. A previous study suggested that the contribution of TGF-b and CLIC4 to myofibroblast conversion of the fetal lung fibroblast cell line MRC5 was mediated by reactive oxygen 43 but we could not reproduce that result in primary skin fibroblasts (data not shown).
CLIC4 status WT KO WT KO TGF-10ng/ml (h)
We attribute the impact of CLIC4 on activation of p38MAPK to reduced interaction of phospho-p38 with its phosphatase PPM1a, thus enhancing the p38 signaling in response to TGF-b. The association of CLIC4 with PPM1a could negatively influence binding of PPM1a to all its substrates and inhibit their subsequent dephosphorylation. We have previously shown that CLIC4 prolongs Smad2/3 signaling by inhibiting their dephosphorylation via reduced access to PPM1a. The present results with p38 strengthen the likelihood of CLIC4 operating via a common mechanism such as binding to PPM1a to prevent its interaction with PPM1a substrates. Theoretically, CLIC4 could either bind the catalytic domain of PPM1a 44 (Supplementary Figure 5 , top panel) and hinder binding to PPM1a substrates or bind in a noncatalytic (beta-pleated) region to change the molecular conformation and disrupt the substrate binding site. By molecular modeling and sequence analysis, it is predicted that CLIC4 may be phosphorylated 45 ( Supplementary Figure 5 , bottom panel) and in such a circumstance, phospho-CLIC4 might bind PPM1a as a substrate. Unphosphorylated CLIC4 may bind the substrate binding (catalytic) pocket of PPM1a as well. It is possible that the smaller size of CLIC4 makes for higher affinity binding to PPM1a than its other substrates. Although, binding of CLIC4 to the non-catalytic domain of PPM1a is possible, if this binding were to be such that it caused a substantial conformational change and destroyed the substrate binding pocket of PPM1a, it would leave PPM1a at a high energy unstable state and hence this possibility is less likely. Therefore by structural modeling prediction, the first possibility seems more probable. These predictions, until experimentally verified, remain mere possibilities and would be a subject of future studies. We show that stromal CLIC4 helps tumor cells migrate, invade and undergo EMT. Underlying this property of CLIC4 is its action to enhance secretion of TGF-b by fibroblasts and its essential role in myofibroblast generation, induction of a-SMA and expression of ECM genes. Myofibroblasts are proinvasive, located mainly at the invasive front in cancer of the colon, breast, liver, lung and pancreas. 46 TGF-b produced by activated tumor stroma is a critical mediator of EMT of nearby carcinoma cells, which would enhance their invasiveness. 47 Enhanced matrix metalloproteinase secretion would increase basement membrane degeneration. Thus, enhanced stromal CLIC4 expression presents a multitude of factors to aid cancer growth and invasion.
With increasing evidence for the importance of tumor-stromal interactions in affecting the behavior of cancer cells, the viability of stromal therapy is being considered. 48 Targeting stromal signals that influence tumor growth and invasion would limit the stromal reaction and cripple the tumor. In this regard, CLIC4 or p38 are attractive targets. Downregulation of CLIC4 in the stroma through antisense/small interfering RNA means would lead to reduced fibroblast transdifferentiation and ECM remodeling and hamper tumor growth. The reduction in tumor growth in absence of stromal CLIC4 in our orthograft assay points to the merit of this approach. Several TGF-b inhibitors are being developed for anticancer therapy. 49, 50 However, targeting the TGF-b pathway could be fraught with severe side effects in light of the friend and foe dual role of TGF-b. [50] [51] [52] Considering the very high level of CLIC4 expressed in the myofibroblast stroma of many epithelial cancers 11, 12 and the marked reduction of myofibroblast markers in the absence of CLIC4, perhaps targeting CLIC4 or p38 would be a more specific approach to inhibit the tumor enhancing aspect of TGF-b signaling and therefore would give better therapeutic outcome. Figure 4 . CLIC4 prolongs p38 phosphorylation by inhibiting interaction of p-p38 and its phosphatase PPM1a. (a) Lysates from CLIC4 WT and KO fibroblasts were immunoprecipitated with anti-PPM1a antibody and immunoblotted for phospho-p38 and PPM1a. Non-immunoprecipitated (input) lysates were immunoblotted for phospho-p38 and CLIC4. Immunoprecipitated p-p38 bands were quantified using Image J software (from National Institutes of Health, Bethesda, MD, USA), normalized to their respective input p-p38 bands and expressed relative to WT. (b) Primary dermal fibroblasts were transduced with vector or CLIC4-expressing adenovirus. Lysates were immunoprecipitated with anti-PPM1a antibody and immunoblotted for phospho-p38, CLIC4 and PPM1a. Non-immunoprecipitated (input) lysates were immunoblotted for phospho-p38 and CLIC4. (a, b) Samples undergoing the immunoprecipitation process without any protein lysate (no lysate) or without antibody (no Ab) were used as controls.
MATERIALS AND METHODS
Cell culture, expression vectors, pathway inhibitors and transfection
Primary dermal fibroblasts from newborn CLIC4 wild-type mice on a C57Bl/6 background or mice from the same breeding colony in which the second exon of CLIC4 is flanked by loxP sites to generate CLIC4 ablated cells on recombination with Cre recombinase (floxed mice) 10 were prepared and cultured according to established methods 53 27 were provided by James Rheinwald (Harvard Medical School). To delete CLIC4 from the floxed fibroblasts, cultured wild-type and floxed cells were exposed to an adenovirus encoding the Cre recombinase (adeno-Cre; kind 
Generation of conditioned media
Conditioned media from mouse keratinocyte cell lines S1 and PAM212 or human breast epithelial cell lines (Ml-MIV) were generated by culturing these cell lines in serum-free media for 72 h. Culture supernatants were then centrifuged at 10 000 r.p.m. and filtered. For generation of conditioned media from CLIC4-overexpressing or control fibroblasts, fibroblasts were transduced with either empty vector or CLIC4-expressing adenovirus for 48 h, and serum-free conditioned medium was subsequently centrifuged and filtered as above. TGF-b concentration was measured in conditioned media using the Quantikine TGF-b1 immunoassay (R&D Systems Inc., Minneapolis, MN, USA) according to the manufacturer's instructions. It was normalized to total cell protein.
Antibodies, immunoprecipitation and immunoblotting
Monospecific polyclonal antibody generated against the N-terminal peptide of CLIC4 has been described elsewhere. 54 
Scratch assay
Scratch Assay was performed using the IncuCyte technology (Essen Bioscience, Ann Arbor, MI, USA). PAM212 cells plated in 24-well IncuCyte image lock plates were scratched using IncuCyte Wound Maker Tool and washed twice with medium. Subsequently, conditioned media, TGF-b or pathway blockers were added to the wells and the scratched area (wound) imaged in a time lapse manner for 24 h using IncuCyte FLR . Results were plotted using the IncuCyte FLR software in terms of percentage wound closure as a function of time.
Matrigel migration assay BD Biocoat matrigel invasion chambers (BD Biosciences, Franklin Lakes, NJ, USA) in a 24-well plate were rehydrated in serum-free Dulbecco's modified Eagle's medium for 2 h in a humidified incubator at 37 1C, 5% CO 2 . In all, 750 ml of conditioned media with or without pathway blockers was added to lower chambers followed immediately by addition of 50 000 PAM212 cells per well in the top chambers. Plates were incubated at 37 1C for 24 h. The top side of the inserts was scrubbed, and the inserts stained in Diff Quick stain, washed and dried. The membranes were cut, mounted on a slide and stained cells were counted under a microscope.
Confocal microscopy
Cells grown in glass chamber slides were fixed in 4% paraformaldehyde/PBS for 20 min, washed with PBS and permeabilized with 0.5% Triton for 10 min. Samples were then blocked in 1% bovine serum albumin/PBS þ 0.1% horse serum for 10 min. This was followed by incubation with anti-CLIC4 antibody (1:100) for 72 h at 4 1C and anti-a-SMA antibody (1:1000) for the last 1 h. Slides were washed with PBS and incubated in the dark with fluorescence-labeled anti-mouse together with anti-rabbit secondary antibody for 45 min. The plates were washed again, Vectashield mounting medium with 4,6-diamidino-2-phenylindole (Vector Laboratories, Burlingame, CA, USA) was added for nuclear staining and cells were analyzed by confocal microscopy using the Zeiss LSM 710 NLO microscope (Carl Zeiss, Germany).
Statistics
All experiments were repeated a minimum of two times and data were subjected to unpaired t-test. Line graphs were evaluated using Mann-Whitney t-tests. P-values are indicated in Figures. ****Po0.0001, ***Po0.0005, **Po0.005, *Po0.05.
